ANO1 and intrahepatic cholangiocarcinoma: Any factor that causes morphological or functional changes in ICC or PDGFRα+ cells may affect the relative balance between ICC-ANO1-SMC and PDGFRα+ cells-SK3-SMC, resulting in abnormal gastrointestinal motility (61).